CA1077932A - Composes de la xanthine pour le traitement des bronchospasmes et des affections allergiques - Google Patents

Composes de la xanthine pour le traitement des bronchospasmes et des affections allergiques

Info

Publication number
CA1077932A
CA1077932A CA274,520A CA274520A CA1077932A CA 1077932 A CA1077932 A CA 1077932A CA 274520 A CA274520 A CA 274520A CA 1077932 A CA1077932 A CA 1077932A
Authority
CA
Canada
Prior art keywords
methyl
alkyl
dimethyl
butyl
xanthine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA274,520A
Other languages
English (en)
Inventor
Julius Diamond
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Berlex Laboratories Inc
Original Assignee
Berlex Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/672,388 external-priority patent/US4120947A/en
Priority claimed from US05/672,437 external-priority patent/US4089959A/en
Application filed by Berlex Laboratories Inc filed Critical Berlex Laboratories Inc
Application granted granted Critical
Publication of CA1077932A publication Critical patent/CA1077932A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA274,520A 1976-03-31 1977-03-22 Composes de la xanthine pour le traitement des bronchospasmes et des affections allergiques Expired CA1077932A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/672,388 US4120947A (en) 1976-03-31 1976-03-31 Xanthine compounds and method of treating bronchospastic and allergic diseases
US05/672,437 US4089959A (en) 1976-03-31 1976-03-31 Long-acting xanthine bronchodilators and antiallergy agents

Publications (1)

Publication Number Publication Date
CA1077932A true CA1077932A (fr) 1980-05-20

Family

ID=27100746

Family Applications (1)

Application Number Title Priority Date Filing Date
CA274,520A Expired CA1077932A (fr) 1976-03-31 1977-03-22 Composes de la xanthine pour le traitement des bronchospasmes et des affections allergiques

Country Status (5)

Country Link
JP (1) JPS52122396A (fr)
CA (1) CA1077932A (fr)
DE (1) DE2713389A1 (fr)
FR (1) FR2346353A1 (fr)
GB (1) GB1561005A (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416810C (sv) 1977-10-14 1982-07-19 Draco Ab Forfarande for framstellning av xantinderivat med antiallergisk aktivitet
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
SE7810946L (sv) * 1978-10-20 1980-04-21 Draco Ab Metod att behandla kronisk obstruktiv luftvegssjukdom
SE8002910L (sv) * 1980-04-18 1981-10-19 Draco Ab 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar
CH643260A5 (fr) * 1980-05-02 1984-05-30 Nestle Sa 1-allyl-3-butyl-8-methylxanthine, procede de preparation et utilisation dans un medicament.
FR2611716A1 (fr) * 1987-03-06 1988-09-09 Uriach Cia Sa J Derives de diisobutylxanthine substituee en position 7 utiles comme bronchodilatateurs, procede pour leur preparation et composition pharmaceutique les contenant
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
US5321029A (en) * 1988-11-14 1994-06-14 Beecham-Wuelfing Gmbh & Co.K.G. Xanthines
IT1229195B (it) * 1989-03-10 1991-07-25 Poli Ind Chimica Spa Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
ATE247116T1 (de) 1994-12-13 2003-08-15 Euro Celtique Sa Arylthioxanthine
EP0799040B1 (fr) 1994-12-13 2003-08-20 Euroceltique S.A. Thioxanthines trisubstituees
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2729643A (en) * 1956-01-03 J-disubstmjied and i

Also Published As

Publication number Publication date
DE2713389A1 (de) 1977-10-13
FR2346353A1 (fr) 1977-10-28
DE2713389C2 (fr) 1992-03-19
JPS5720313B2 (fr) 1982-04-27
GB1561005A (en) 1980-02-13
FR2346353B1 (fr) 1980-03-07
JPS52122396A (en) 1977-10-14

Similar Documents

Publication Publication Date Title
US4089959A (en) Long-acting xanthine bronchodilators and antiallergy agents
US4120947A (en) Xanthine compounds and method of treating bronchospastic and allergic diseases
CA1077932A (fr) Composes de la xanthine pour le traitement des bronchospasmes et des affections allergiques
US5734051A (en) 8-substituted xanthine derivatives and method of use thereof
US4644001A (en) 3-Alkylxanthines, composition and methods for the treatment of chronic obstructive-airway disease and cardiac disease
AU683270B2 (en) Novel chemical compounds having PDE-IV inhibition activity
EP0011609B1 (fr) Dérivés de xanthine et préparation pharmaceutique les contenant pour utilisation dans le traitement de maladies chroniques d'obstruction des voies respiratoires et de maladies cardiaques
PL166152B1 (en) Method of obtaining novel xantine derivatives
CA2209125A1 (fr) Composes et procede pour inhiber la phosphodiesterase iv
EP0001735A1 (fr) Dérivés de xanthine à activité antiallergique et compositions pharmaceutiques les contenant
JPH0780882B2 (ja) ６‐チオキサンチン誘導体
CA1271473A (fr) Les 8-arylxanthines
US6440979B1 (en) Aryl isoguanines
CA1156229A (fr) 3,8-dialkylxanthines, methodes pour les preparer, composition et methodes pour le traitement de l'obstruction chronique des voies aeriennes et des maladies cardio-vasculaires
US6319928B1 (en) Purine derivatives having phosphodiesterase IV inhibition activity
EP0531349A1 (fr) Derives de xanthine substitues en positions 1-7 possedant une activite anti-asthmatique, leurs sels acceptables sur le plan physiologique, composition pharmaceutique les contenant et procede de preparation
US6294541B1 (en) Purine derivatives having phosphodiesterase IV inhibition activity
US6248746B1 (en) 3-(arylalkyl) xanthines
DE69531555T2 (de) Dreifachsubstituierte thioxanthine
CA1142928A (fr) 3-alkylxanthines, intermediaires, procedes de preparation, composition et methodes pour le traitement de l'obstruction chronique des voies respiratoires et des maladies cardiaques
JPH05262770A (ja) 化学的製法
EP0407651A2 (fr) Utilisation de 1,3-diisobutyl-8-méthylxanthine comme bronchodilatateur et agent anti-allergique

Legal Events

Date Code Title Description
MKEX Expiry